Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > ARC Dialysis

<< Previous

Bullboard Posts

Next >>

Comment by JustCheckingInon Jun 16, 2022 6:34am

161 Views

Post# 34760423

RE:RE:RE:RE:RE:RE:RE:RE:RE:ARC Dialysis

I'll give you nothing Rikkie.

It is not my role or inclination to assist lazy, uninformed investors.

What you are looking at are the 12 physical locations of ARC's wholly owned and run Dialysis.

Beyond that however the news release quite and obviously states that they are in 6 other South Eastern states where they run the dialysis for several hospital networks, Long Term Care facilities and nursing homes.

My analysis, which I have no compunction to share with you, says that represents hundreds of individual Arc Managed dialysis sites, across 7 states.

Read it again Rikkie, and maybe an 8th time and you may grasp what the news release is actually telling you.

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly